|
Match
|
Document |
Document Title |
|
|
7622491 |
Modulators of PPAR and methods of their preparation
The present invention is directed to certain novel compounds represented by Formula (I) and pharmaceutically acceptable salts, solvates, hydrates and prodrugs thereof. The present invention is also...
|
|
|
7612210 |
Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
A process for the enantioselective synthesis of an (S)- or (R)-1-[2-dimethylamino)-1-(methoxyphenyl)ethyl]cyclohexanol and analogues or salt thereof are described. The method involves the steps of...
|
|
|
7612209 |
Pseudo proline dipeptides
Disclosed is a process for the manufacture of pseudo proline dipeptides of the formula
wherein R 1 is a side chain of an alpha amino acid, R 2 is an amino protecting group and R 3 and R 4 ...
|
|
|
7608564 |
3-heterocyclyl-substituted benzoyl derivatives
Benzoyl derivatives of the formula I
where the variables have the following meanings:
R 1 , R 2 are hydrogen, nitro, halogen, cyano, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio,...
|
|
|
7608244 |
Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients
Highly hydrophilic indole and benzoindole derivatives that absorb and fluoresce in the visible region of light are disclosed. These compounds are useful for physiological and organ function...
|
|
|
7595334 |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
The present invention concerns the compounds having the formula
N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein R 1 and R 8 each are...
|
|
|
7589196 |
Amine-substituted biphenyldiphosphines
1,1′-Biphenyl-2,2′-diphosphines having at least one amine substituent in the para position relative to the phosphine group and having the formulae
are ligands for metal complexes which...
|
|
|
7585880 |
Phenylpropanoic acid derivatives
The present invention provides a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, a drug for the prophylaxis or treatment of diabetes...
|
|
|
7579478 |
Process for the purification of substituted benzoxazole compounds
The present invention provides processes for the purification of substituted benzoxazole compounds, and in particular 2-(3-fluoro-4-hydroxy-phenyl)-7-vinyl-benzooxazol-5-ol. The processes include...
|
|
|
7563904 |
Synthesis intermediates useful for preparing zolmitriptan
In particular, this invention relates to the synthesis intermediates (IV), (V), (VI) and (VIII) useful for preparing zolmitriptanzohnitriptan or a pharmaceutically acceptable salt thereof, which...
|
|
|
7560569 |
Bicycloamide derivative
Novel bicycloamide derivatives (general formula (1)) and pharmaceutically acceptable salts thereof effectively inhibit DPP-IV. The bicycloamide derivatives are represented by the general formula...
|
|
|
7556797 |
Minimally invasive physiological function monitoring agents
Highly hydrophilic indole and benzoindole derivatives that absorb and fluoresce in the visible region of light are disclosed. These compounds are useful for physiological and organ function...
|
|
|
7553964 |
Cyclobutyl amine derivatives
Compounds of formula (I)
are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising...
|
|
|
RE40795 |
Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
A process for producing heterocyclic compounds which are useful as pesticides, drugs, fungicidal materials or intermediates thereof. TosMIC is reacted with an aldehyde or an imino compound: 1) in a...
|
|
|
7547790 |
Optically active 4,4-di-substituted oxazolidine derivative and method for producing same
An optically active 4,4-di-substituted oxazolidine compound having the formula (I)
wherein R 1 represents a substituted C 1 -C 3 alkyl group, a substituted C 2 -C 3 alkenyl group, a...
|
|
|
7538130 |
Hindered amine light stabilizer, methods of making, and compositions
A compound
in which n is 0, 1, 2, or 3; R 1 , R 2 , R 7 , and R 8 are each independently alkyl group, including cycloalkyl, an alkylaryl group, or an aryl group, optionally with one or more...
|
|
|
7534804 |
Benzoxazole inhibitors of 15-lipoxygenase
The present application provides benzoxazole inhibitors of 15-LO, pharmaceutical compositions containing such inhibitors and methods for treating diseases related to the 15-LO cascade using such...
|
|
|
7534751 |
Photo-labile pro-fragrance conjugates
The present invention relates to photo-labile pro-fragrance conjugates comprising:
a) a photo-labile unit which upon exposure to electromagnetic radiation is capable of releasing a pro-fragrance...
|
|
|
7524869 |
Taxanes having a C10 ester substituent
Taxanes having an ester substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substituents.
|
|
|
7521563 |
Hydroxamic acid derivative and medicine containing the same as active ingredient
A compound which inhibits the production of IL-6 and/or TNFα by inflammatory cytokines and is useful in the prevention of or treatments for diseases such as various inflammatory diseases in which...
|
|
|
7517902 |
Substituted indazoles, compositions containing the same, and the preparation and use thereof
Disclosed are novel substituted indazole compounds, pharmaceutical compositions comprising such compounds, and methods of treatment comprising such compounds.
|
|
|
7511034 |
Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
Novel dialkylhydroxybenzoic acid derivatives containing metal chelating groups are disclosed. The novel compounds are used as therapeutics for treating and/or preventing various medical...
|
|
|
7504520 |
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof
The present invention is directed to compounds of formula (I)
wherein variables W, X, Y, D, A, n, R 1 , R 2 and R 9 are as defined in the description.
|
|
|
7491733 |
Bicyclic guanidine derivatives and therapeutic uses thereof
The invention relates to compounds of general formula (I), in which A, X, Y and R1 are defined in Claim 1 . These compounds may be used in the treatment of pathologies associated with insulin...
|
|
|
7476686 |
Substituted aryl thioureas and related compounds; inhibitors of viral replication
The invention provides compounds and pharmaceutically acceptable salts of Formula I
wherein the variables A 1 , A 2 , R 1 , R 2 , V, W, X, Y, and Z are defined herein. Certain compounds of...
|
|
|
7470794 |
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors
Ortho-sulfonamido aryl hydroxamic acids are provided which are useful, inter alia, for the inhibition of matrix metalloproteinases and the treatment of conditions associated with overexpression of...
|
|
|
7468437 |
Phenyl pyrrolidine ether tachykinin receptor antagonists
The present invention is directed to certain phenyl pyrrolidine ether compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular...
|
|
|
7465748 |
Amide derivative
There is provided a pharmaceutical drug, particularly a novel compound useful for prophylaxis or a therapeutic treatment of various diseases involving infections with viruses of the herpesvirus...
|
|
|
7452899 |
Gamma-secretase inhibitors
Compounds of Formula (I): inhibit the processing of APP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease.
|
|
|
7442486 |
Radiation-sensitive compositions comprising oxazole derivatives and imageable elements based thereon
Radiation-sensitive element comprising: (a) one or more types of monomers each comprising at least one ethylenically unsaturated group accessible to a free-radical polymerization, (b) at least one...
|
|
|
RE40558 |
Therapeutic uses of di-aryl acid derivatives
The use of diaryl acid derivatives of formula (I)
or pharmaceutically acceptable salts, N-oxides, hydrates or solvates thereof, wherein the variables shown are defined in the disclosure, and...
|
|
|
7435751 |
7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
The present invention provides a compound of formula I
or a pharmaceutically acceptable salt thereof wherein R 1 is C 1-4 alkyl, optionally substituted with a fluoro atom, or R 1 is a...
|
|
|
7432293 |
Heterocyclic compounds useful as Nurr-1 activators
The present invention relates to compounds of formula (I): wherein R 1 is hydroxy, C 1-4 alkoxy, amino, C 1-4 alkyl-amino, di C 1-4 alkylamino, benzyloxy or C 2 -C 7 alkanoyl, R 2 is C 1-4 ...
|
|
|
7432290 |
Inhibitors of IMPDH enzyme
The present invention relates to compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions...
|
|
|
7429581 |
Pyrazole-derivatives as factor Xa inhibitors
The present invention is directed to a compound of formula I,
in which R 0 ; R 1 ; R 2 ; R 3 ; R 4 ; Q; V, G and M have the meanings indicated below. The compound of formula I is a...
|
|
|
7425633 |
Pyrrolidine compounds
A compound of the following formula:
wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , T, X, Y, and Z are as defined herein. Also disclosed is a method for inhibiting dipeptidyl peptidase...
|
|
|
7425221 |
Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use
The invention relates to a composition comprising, in a cosmetically acceptable medium, at least one particular direct dye. The invention further relates to a method for treating keratin fibers,...
|
|
|
7417030 |
Indazole peptidomimetics as thrombin receptor antagonists
The invention is directed to novel indazole peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis,...
|
|
|
7396847 |
Oxazolidinone and/or isoxazoline as antibacterial agents
Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof,
and compounds as shown in (I) wherein C is for example
wherein A and B are...
|
|
|
7378421 |
Chromenone derivatives
Novel compounds of the formula I
in which
R 1 , R 2 , R 3 and Het are as defined herein, which
are inhibitors of tyrosine kinases and/or Raf kinases and can be employed for the treatment of...
|
|
|
7378397 |
TRH-degrading ectoenzyme inhibitors
Peptide derivatives useful as inhibitors of activity of thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) are of formula I a :
wherein:
R 1 is an optionally substituted 4-, 5-...
|
|
|
7371777 |
Cyclic compound and PPAR agonist
The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester...
|
|
|
7368578 |
Five-membered heterocyclic compounds
The present invention provides a compound represented by the formula:
wherein R 1 is an optionally substituted 5-membered heterocyclic group; X, Y and V are the same or different and each is a...
|
|
|
7361755 |
Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
This invention pertains to a novel process for preparing sterically hindered N-substituted alkyloxyamines from alkenes by the transition-metal-catalyzed reaction of a intermediate alkylborane with...
|
|
|
7351728 |
Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists
Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl,...
|
|
|
7342039 |
Substituted indole oximes
The present invention relates to substituted indole oximes and methods of using them.
|
|
|
7342035 |
Process for preparing zolmitriptan compounds
In particular, zolmitriptan or a pharmaceutically acceptable salt thereof, which includes a) Preparation of the diazonium salt of the aniline hydrochloride (II); followed by reduction and...
|
|
|
7342030 |
Indole derivatives
The present invention relates to the compounds of formula I:
their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned...
|
|
|
7335775 |
Effector conjugates, process for their production and their pharmaceutical use
Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted...
|
|
|
7335671 |
Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals The invention relates to arylcycloalkyl-substituted alkanoic acid derivatives...
|